AMITRIPTYLINE 25 TAB DIN 00448818
Status: Cancelled Post Market
Holder: DUCHESNAY INC
Health Canada record
| Active ingredient(s) | AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE) 25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AA09 AMITRIPTYLINE |
| Original market date | 31-Dec-1981 |
| Current status date | 18-Jul-2003 |
| Source | Health Canada DPD |
Establishment licence of the holder
Duchesnay Inc. — licence 100948, currently licensed, last inspection rating C (2023-12-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00448796 | AMITRIPTYLINE 10 TAB | DUCHESNAY INC | Tablet | AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE) 10 MG | Cancelled Post Market |